Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Van Praet

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
The Lancet. Oncology|September 13, 2024
[<sup>89</sup>Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trialBrian Shuch, Allan J Pantuck, Jean-Christophe Bernhard, et al.
Urologic Oncology|February 7, 2016
Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use programCharles Van Praet, Sylvie Rottey, Fransien Van Hende, et al.
Clinical Genitourinary Cancer|March 5, 2017
Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel?Charles Van Praet, Sylvie Rottey, Fransien Van Hende, et al.
World Journal of Urology|November 2, 2024
Outcomes after robot-assisted radical cystectomy with orthotopic neobladder in womenJuhana Rautiola, Alberto Martini, Laura S Mertens, et al.
Acta Physiologica (Oxford, England)|July 24, 2023
Extensive profiling of histidine-containing dipeptides reveals species- and tissue-specific distribution and metabolism in mice, rats, and humansThibaux Van der Stede, Jan Spaas, Sarah de Jager, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
The Lancet. Oncology|September 13, 2024
[<sup>89</sup>Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trialBrian Shuch, Allan J Pantuck, Jean-Christophe Bernhard, et al.
Urologic Oncology|February 7, 2016
Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use programCharles Van Praet, Sylvie Rottey, Fransien Van Hende, et al.
Clinical Genitourinary Cancer|March 5, 2017
Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel?Charles Van Praet, Sylvie Rottey, Fransien Van Hende, et al.
World Journal of Urology|November 2, 2024
Outcomes after robot-assisted radical cystectomy with orthotopic neobladder in womenJuhana Rautiola, Alberto Martini, Laura S Mertens, et al.
Acta Physiologica (Oxford, England)|July 24, 2023
Extensive profiling of histidine-containing dipeptides reveals species- and tissue-specific distribution and metabolism in mice, rats, and humansThibaux Van der Stede, Jan Spaas, Sarah de Jager, et al.
Pageof 8